FDA Inspection 1111589 — Biowy Corporation
The FDA completed an inspection of Biowy Corporation on November 8, 2019 in Lake Forest, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 8, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lake Forest, CA (United States)